In in vitro models (INS-1, MIN6, TC-6 lines, SH-SY5Y neural cells, HEK293 transfected with GLP-1R) studies of receptor affinity, activation kinetics and the effect on the expression of metabolic-response genes (PDX-1, GLUT2, glucokinase) are carried out
If you are experiencing side effects, your provider will not increase your dose and may adjust your plan
The choice between these medications requires a thoughtful evaluation of individual needs, priorities, and treatment goals, underscoring the importance of personalized medicine in navigating the landscape of GLP-1 receptor agonists
The medication will no longer provide the same pharmacological action as it did before the expiry date
Maintain aseptic handling practices to ensure product quality and sterility